Lanean...
Promising therapies for treatment of nonalcoholic steatohepatitis
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) has become the most common etiology for abnormal aminotransferase levels and chronic liver disease. Its growing prevalence is largely linked to the presence of metabolic syndrome, particularly diabetes and insulin resistance. It is estimated th...
Gorde:
| Argitaratua izan da: | Expert Opin Emerg Drugs |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906104/ https://ncbi.nlm.nih.gov/pubmed/27501374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728214.2016.1220533 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|